"Designing Growth Strategies is in our DNA"

U.S. Allergy Immunotherapy Market Size, Share, Analysis, By Type (Subcutaneous Immunotherapy and Sublingual Immunotherapy), By Application (Allergic Rhinitis, Allergic Asthma, and Others), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies & Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI108966

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence/Incidence Allergic Rhinitis, and Asthma, 2023
    2. Key Industry Developments: Mergers, Acquisition, Partnerships, etc.
    3. Launch of New Products
    4. Impact of COVID-19 on the Market
  5. U.S. Allergy Immunotherapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Subcutaneous Immunotherapy
      2. Sublingual Immunotherapy
    2. Market Analysis, Insights and Forecast – By Application
      1. Allergic Rhinitis
      2. Allergic Asthma
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. ALK
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Stallergenes Greer
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Allergy Therapeutics
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. HollisterStier Allergy
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Dermapharm Holding SE
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. HAL Allergy B.V.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence/Incidence Allergic Rhinitis, and Asthma, 2023
    2. Key Industry Developments: Mergers, Acquisition, Partnerships, etc.
    3. Launch of New Products
    4. Impact of COVID-19 on the Market
  5. U.S. Allergy Immunotherapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Subcutaneous Immunotherapy
      2. Sublingual Immunotherapy
    2. Market Analysis, Insights and Forecast – By Application
      1. Allergic Rhinitis
      2. Allergic Asthma
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. ALK
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Stallergenes Greer
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Allergy Therapeutics
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. HollisterStier Allergy
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Dermapharm Holding SE
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. HAL Allergy B.V.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Allergy Immunotherapy Market Revenue Breakdown (USD million, %), By Type, 2024 & 2032

Figure 2: U.S. Allergy Immunotherapy Market Value Share (%), by Type, 2024 & 2032

Figure 3: U.S. Allergy Immunotherapy Market Value Share (%), by Application, 2024 & 2032

Figure 4: U.S. Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5: U.S. Allergy Immunotherapy Market Share (%), By Company, 2023

Table 1: U.S. Allergy Immunotherapy Market Revenue (USD million) Forecast, by Type, 2019–2032

Table 2: U.S. Allergy Immunotherapy Market Revenue (USD million) Forecast, by Application, 2019–2032

Table 3: U.S. Allergy Immunotherapy Market Revenue (USD million) Forecast, by Distribution Channel, 2019–2032

U.S. Allergy Immunotherapy Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports